Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001104659-23-023041

Options or other derivatives

  • Director acquired 801,924 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Juvenescence Ltd Director 2023-02-16 Grant or award · Warrant to Purchase Common Stock +801,924 801,924 D: show line 1 in the form
Loading xslF345X03/tm234525-2_4seq1.xml…